Literature DB >> 105228

Effects of insulin infusion on plasma phosphate in diabetic patients.

M S Riley, D S Schade, R P Eaton.   

Abstract

A clinical association between insulin therapy and hypophosphatemia has frequently been made but a dose-response relationship has not been reported. Furthermore, the rapidity by which hypophosphatemia may be induced following an increment in plasma-free insulin concentration is not well defined. Therefore this study compared the effects of different rates of insulin infusion on the changes in plasma phosphate concentration in ketotic, hyperglycemic diabetic man. Sixteen prospective studies were performed in four insulin-dependent ketotic diabetic subjects. Insulin was infused according to one of four different protocols: high dose (1.0 U/kg/hr), low dose (0.1 U/kg/hr), very low dose (0.01 U/kg/hr) and control (saline only). Plasma phosphate, glucose, and free insulin concentrations were measured sequentially during the 60 min infusion periods. We observed that plasma phosphate concentrations declined significantly only with low-dose and high-dose insulin infusions. The magnitude and rapidity of fall of the mean phosphate concentration were greatest with high-dose insulin infusion. Significant hypophosphatemia can be observed within 30 min following the onset of insulin therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 105228     DOI: 10.1016/0026-0495(79)90063-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Diabetic ketoacidosis.

Authors:  D R Owens
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

2.  Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.

Authors:  Christina Cicerchi; Nanxing Li; James Kratzer; Gabriela Garcia; Carlos A Roncal-Jimenez; Katsuyuki Tanabe; Brandi Hunter; Christopher J Rivard; Yuri Y Sautin; Eric A Gaucher; Richard J Johnson; Miguel A Lanaspa
Journal:  FASEB J       Date:  2014-04-22       Impact factor: 5.191

Review 3.  Diabetic ketoacidosis.

Authors:  D G Patel; S C Kalhan
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

4.  Hyperphosphataemia after enemas in childhood: prevention and treatment.

Authors:  M F Hunter; M R Ashton; D M Griffiths; P Ilangovan; J P Roberts; V Walker
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  [Differences in postoperative metabolism after pre- and postoperative beginning of total parenteral nutrition].

Authors:  M Georgieff; R Kattermann; K Geiger; L W Storz; U Bethke; H Lutz
Journal:  Z Ernahrungswiss       Date:  1980-06

Review 6.  [Theory and practice of perioperative trauma-adapted parenteral feeding].

Authors:  M Georgieff
Journal:  Z Ernahrungswiss       Date:  1982-12

7.  Circadian variation of mineral and bone parameters in end-stage renal disease.

Authors:  Hariprasad Trivedi; Aniko Szabo; Shi Zhao; Tom Cantor; Hershel Raff
Journal:  J Nephrol       Date:  2014-08-20       Impact factor: 3.902

8.  The role of distubances of phosphate metabolism in metabolic syndrome.

Authors:  Marilena Stoian; Victor Stoica
Journal:  Maedica (Buchar)       Date:  2014-09

Review 9.  ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

Authors:  D B Dunger; M A Sperling; C L Acerini; D J Bohn; D Daneman; T P A Danne; N S Glaser; R Hanas; R L Hintz; L L Levitsky; M O Savage; R C Tasker; J I Wolfsdorf
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

10.  Insulin suppresses the production of fibroblast growth factor 23 (FGF23).

Authors:  Ludmilla Bär; Martina Feger; Abul Fajol; Lars-Oliver Klotz; Shufei Zeng; Florian Lang; Berthold Hocher; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.